RVL Pharmaceuticals plc (NASDAQ:RVLP) Q2 2023 Earnings Call Transcript

RVL Pharmaceuticals plc (NASDAQ:RVLP) Q2 2023 Earnings Call Transcript August 14, 2023

RVL Pharmaceuticals plc misses on earnings expectations. Reported EPS is $-0.2404 EPS, expectations were $0.13.

Operator: Good day, and thank you for standing by. Welcome to the RVL Pharmaceuticals Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question and answer session. [Operator Instructions]...